Wednesday, October 19, 2022
8 a.m. PDT | 11 a.m. EDT | 5 p.m. CET
For biotech companies, finding the right partner for cell line development is essential to producing effective, high-quality target proteins.
In this webinar, learn more about SpikImm’s monoclonal antibody therapy targeting COVID-19 infection, and how the biotech partnered with Sartorius to streamline cell line development and accelerate time to market.
What Will You Learn:
Review key considerations for selecting a CLD partner, including extensive experience and availability of state-of-the-art facilities.
Learn how media considerations play a key role in cell line development.
Discover how a producer of monoclonal antibody-based therapies partnered with a CLD service provider to accelerate commercialization.
Meet Our Experts:
Jérôme Tiollier, PhD
President NOCOLEM – Consulting Boutique in Biologics Development | Executive Chairman – Jalon Therapeutics
Jérôme Tiollier has more than 30 years of pharmaceutical R&D experience in various senior leadership positions, helping to develop first-in-class products for Imedex, Imtix Sangstat, and Innate Pharma. He has managed multiple areas of drug development, including CMC toxicology, PK, drug nonclinical demonstration, translational scientific research, and early-phase clinical and regulatory operations.
Regional Marketing Manager EMEA, Cell Line, Media and Testing Solutions
Sandrine Chevalier has worked for Sartorius since 2021 as Regional Marketing Manager EMEA for Cell Line, Media and Testing Solutions. She has more than 15 years’ experience in the pharma and biotech industries, where she has held various Product and Marketing and Business Manager roles. She has a master’s degree in Cellular and Molecular Biology and Oncology and an MBA in Pharmaceutical Management.
Dr. Lisa Blaschke
Product Manager, CLD Services
Lisa Blaschke has been working for Sartorius since 2017 in various roles. She earned her phD in the field of technical biology from the University of Stuttgart, Germany, and started her career as an Application Specialist for CLD services at Sartorius. In this role, she was responsible for technical client conversations, scoping out their CLD projects and ensuring clients’ needs are met. In 2020, Lisa was assigned a project leader, where she led various projects focused on launching new cell lines and cell culture media products. Since April 2022, she is now driving forward the strategic development of Sartorius’ CHO cell line development portfolio.